Company intelligence / Profile preview

IRadimed

Winter Springs, Florida, United States of Americairadimed.com ↗

Ownership: Public · IRMD
Employees: ~160
Development stage: Commercial

Overview

IRadimed’s products are FDA-cleared and commercially available. The company has established itself as the only provider of non-magnetic IV infusion pumps and patient monitors designed specifically for use in high-field MRI environments. Their devices are widely adopted by hospitals and acute care facilities globally, with a strong record of revenue growth over multiple consecutive quarters. No clinical trial results apply as these are medical devices.

Therapeutic areas: OtherNeurology
Modalities: Device (MRI-compatible IV infusion pump)Device (MRI-compatible patient vital signs monitor)Device (Ferrous metal detector)
Industry: Therapeutic Medical Devices

Partnerships

None publicly disclosed; company sells directly to hospitals in US and via distributors internationally

Financials

Market cap: $1.1B
Total revenue: $20.5M
Enterprise value: $1B

Beyond the preview

Go deeper on IRadimed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IRadimed.

Explore the full profile